Search Results
Dec 19, 2025, 09:00 ET Ultimate Cannabis Asset (UCASU) to Expand "Best Performing Cannabis Portfolio" by 400% in 2026
Partnership (OTCQB: UCASU) today issued a statement applauding President' Trump's decision to rescheduling marijuana from Schedule I to Schedule III, which is a significant measure of deregulation for cannabis industry. UC Asset, which stands for Ultimate Cannabis Asset, is one of the only
More news about: UC Asset Limited Partnership
Dec 19, 2025, 08:31 ET A New Upmarket Romance Trilogy Exploring Love, Art, and Desire Across Three Continents
negotiate Colin's release from domestic terrorists. There, she meets Ghali, a Muslim Berber who believes in polygamy and maintains a harem.Part III: The artist travels to Hispaniola — Autumn escapes the domestic terrorists in the Sahara Desert and flees to Hispaniola, where she is pursued by
More news about: Edwina Louise Dorch
Dec 19, 2025, 08:03 ET Bright Power Reports on 2025 Achievements and Previews New AI-Driven Solutions and Design Capabilities for 2026
Phius verifier and provided building commissioning services for the ground-breaking, first modular Passive House building in NYC.Castle III - Provided Enterprise Green Communities and Energy Star Multifamily New Construction certification consulting and performed energy code inspections,
More news about: Bright Power INC
Dec 19, 2025, 07:45 ET BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Directors," "Compensation Discussion and Analysis," "Compensation and Equity Tables," and "Share Ownership of Certain Beneficial Owners and Management," and (iii) other documents subsequently filed with the SEC from time to time, including the Proxy Statement to be filed by Amicus in connection with the proposed
More news about: BioMarin Pharmaceutical Inc.
Dec 19, 2025, 03:16 ET Aquaporin initiates rights issue
States of America, including, but not limited to, the United States Treasury Department's Office of Foreign Assets Control, (ii) the United Nations, (iii) the European Union and/or any member state thereof, (iv) the State Secretariat of Economic Affairs of Switzerland, (v) HM Treasury of the United Kingdom,
More news about: Aquaporin A/S
Dec 19, 2025, 03:11 ET Aquaporin initiates rights issue
States of America, including, but not limited to, the United States Treasury Department's Office of Foreign Assets Control, (ii) the United Nations, (iii) the European Union and/or any member state thereof, (iv) the State Secretariat of Economic Affairs of Switzerland, (v) HM Treasury of the United Kingdom,
More news about: Aquaporin A/S
Dec 18, 2025, 18:14 ET Halper Sadeh LLC Encourages FRGE, THS, SNDA, AWK Shareholders to Contact the Firm to Discuss Their Rights
learn more about your legal rights and options.TreeHouse Foods, Inc. (NYSE: THS)'s sale to Industrial F&B Investments III Inc. for $22.50 in cash per share plus a contingent value right. If you are a TreeHouse shareholder,
More news about: Halper Sadeh LLP
Dec 18, 2025, 18:07 ET AtomVie Global Radiopharma conclut un accord de fourniture avec Ionetix Corporation pour accélérer le développement de la radiothérapie à l'Ac-225
logistique, combinés à une infrastructure spécialisée pour le développement de produits radiopharmaceutiques, depuis les études cliniques, phases I à III jusqu'à la commercialisation. AtomVie travaille actuellement avec des clients internationaux qui mènent des études cliniques dans plus de 28 pays à travers
More news about: AtomVie Global Radiopharma Inc.
Dec 18, 2025, 18:00 ET National Safety Council Statement on President Trump's Executive Order to Expedite Cannabis Rescheduling
leading cause of death for U.S. workers is transportation-related incidents. While there are inherent risks to rescheduling cannabis to Schedule III, this action would remove tremendous barriers to potential academic and scientific research opportunities and help safety practitioners better understand
More news about: National Safety Council
Dec 18, 2025, 17:50 ET Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution
distribution amount per common share, attributable to (i) current and prior fiscal year net investment income, (ii) net realized short-term capital gain, (iii) net realized longterm capital gain and (iv) return of capital or other capital source as a percentage of the total distribution amount. These percentages
More news about: Calamos Investments
Dec 18, 2025, 17:34 ET DUTCHIE CELEBRATES HISTORIC CANNABIS RECLASSIFICATION FROM SCHEDULE I TO SCHEDULE III
and Canada, commends today's historic executive order expediting the reclassification of cannabis from a Schedule I controlled substance to Schedule III.
More news about: Dutchie
Dec 18, 2025, 16:39 ET AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis
significantly affect a cannabis-related company's ability to secure financing, (ii) impact the market for marijuana industry sales and services, and (iii) set limitations on marijuana use, production, transportation, and storage. Cannabis-related companies may also be required to secure permits and authorizations
More news about: AdvisorShares
Dec 18, 2025, 16:06 ET Shrub Oak International School Highlights Dr. Andrea Rosa, DNP, PMHNP-BC, Director of Health and Wellness
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on
More news about: Shrub Oak International School
Dec 18, 2025, 16:00 ET LEIFRAS Co., Ltd. Reports Financial Results for the Nine Months Ended September 30, 2025
for the Company's initial public offering ("IPO"), (ii) the increase in promotion fees of JPY8.2 million ($0.06 million) due to business expansion, (iii) the increase in office rental fees of JPY14.1 million ($0.1 million) due to business expansion, (iv) the increase in system maintenance fee expenses
More news about: LEIFRAS Co., Ltd.
Dec 18, 2025, 15:57 ET APhA highlights pharmacists' expertise at marijuana rescheduling ceremony
the rescheduling of marijuana as a Schedule III drug. Marijuana's Schedule I classification imposes strict regulatory requirements that make it difficult for researchers and scientists to obtain it for study. APhA believes that moving marijuana to Schedule III will help accelerate research into its medicinal
More news about: American Pharmacists Association
Dec 18, 2025, 15:12 ET PBC Conference 2026 will highlight Cannabis Banking impact of Federal Cannabis Rescheduling
WASHINGTON, Dec. 18, 2025 /PRNewswire/ -- The Trump administration's decision to reschedule cannabis to Schedule III marks the most significant shift in federal cannabis policy in decades. While the change does not eliminate regulatory requirements, it does reduce tax
More news about: PBC Conference
Dec 18, 2025, 14:40 ET Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act
Trump Administration's action to implement the most impactful federal cannabis reform of the past fifty years by rescheduling cannabis as a Schedule III substance under the Controlled Substances Act of 1970.
More news about: Curaleaf Holdings, Inc.
Dec 18, 2025, 14:07 ET Trulieve Applauds Trump Administration Decision To Reschedule Marijuana to Schedule III
throughout this process."Reclassification of marijuana to Schedule III does not legalize marijuana but it is an important first step in achieving practical common sense cannabis reform. Moving marijuana to Schedule III opens the door for more robust research of medical marijuana, removes the punitive
More news about: Trulieve Cannabis Corp.
Dec 18, 2025, 11:33 ET AtomVie Global Radiopharma firma un acuerdo de suministro con Ionetix Corporation
normativos, de calidad y logísticos, combinados con una infraestructura especializada para el desarrollo de radiofármacos, desde estudios clínicos, fases I a III, hasta los mercados comerciales. AtomVie presta actualmente sus servicios a clientes internacionales que realizan estudios clínicos en más de 28 países
More news about: AtomVie Global Radiopharma Inc.
Dec 18, 2025, 11:32 ET AtomVie Global Radiopharma schließt Liefervertrag mit Ionetix Corporation zur Beschleunigung der Entwicklung von Ac-225-Strahlentherapeutika
Dienstleistungen in Verbindung mit einer spezialisierten Infrastruktur für die Entwicklung von Radiopharmazeutika von klinischen Studien der Phasen I bis III bis hin zu den kommerziellen Märkten. AtomVie betreut derzeit internationale Kunden, die klinische Studien in über 28 Ländern weltweit durchführen. AtomVie
More news about: AtomVie Global Radiopharma Inc.
Dec 18, 2025, 09:00 ET Freda Key C Presents Advanced Recombinant Collagen Delivery Technology at SCC79
challenge.At SCC79, Freda introduced two proprietary delivery strategies for high-molecular-weight RHC-III. The first is a cell-penetrating peptide–fused recombinant Type III collagen (CPP-RHC-III), designed so that the collagen molecule carries its own "engine" to help it pass through the skin. Through
More news about: Shandong Freda Biotech Co., Ltd.
Dec 18, 2025, 09:00 ET Invesco Real Estate Income Trust Inc. Fully Subscribes $87 Million DST Offering
IREX III Industrial Portfolio DST consists of three industrial properties diversified across two states – Ohio and Illinois – and are 100% occupied across 795,825 of net rentable square feet."We believe the strong demand for IREX III reflects a growing investor preference
More news about: Invesco Real Estate Income Trust Inc.
Dec 18, 2025, 09:00 ET The Gross Law Firm Reminds Skye Bioscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - SKYE
effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.DEADLINE: January 16, 2026 Shareholders
More news about: The Gross Law Firm
Dec 18, 2025, 09:00 ET Lost Money on DeFi Technologies(DEFT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly,
More news about: The Gross Law Firm
Dec 18, 2025, 09:00 ET Firefly Aerospace Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - FLY
for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'
More news about: The Gross Law Firm